285 related articles for article (PubMed ID: 23795353)
1. [Prognostic value of tumor-infiltrating immune cells in melanoma].
Ladányi A
Magy Onkol; 2013 Jun; 57(2):85-95. PubMed ID: 23795353
[TBL] [Abstract][Full Text] [Related]
2. Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma.
Ladányi A
Pigment Cell Melanoma Res; 2015 Sep; 28(5):490-500. PubMed ID: 25818762
[TBL] [Abstract][Full Text] [Related]
3. [Function and prognostic significance of immune cells infiltrating human tumors].
Ladányi A
Magy Onkol; 2004; 48(1):49-56. PubMed ID: 15105896
[TBL] [Abstract][Full Text] [Related]
4. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
5. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
Erdag G; Schaefer JT; Smolkin ME; Deacon DH; Shea SM; Dengel LT; Patterson JW; Slingluff CL
Cancer Res; 2012 Mar; 72(5):1070-80. PubMed ID: 22266112
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of B-cell density in cutaneous melanoma.
Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
Jensen TO; Schmidt H; Møller HJ; Donskov F; Høyer M; Sjoegren P; Christensen IJ; Steiniche T
Cancer; 2012 May; 118(9):2476-85. PubMed ID: 21953023
[TBL] [Abstract][Full Text] [Related]
8. Innate immunity in cutaneous melanoma.
Mignogna C; Scali E; Camastra C; Presta I; Zeppa P; Barni T; Donato G; Bottoni U; Di Vito A
Clin Exp Dermatol; 2017 Apr; 42(3):243-250. PubMed ID: 28052512
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.
Hillen F; Baeten CI; van de Winkel A; Creytens D; van der Schaft DW; Winnepenninckx V; Griffioen AW
Cancer Immunol Immunother; 2008 Jan; 57(1):97-106. PubMed ID: 17602225
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
[TBL] [Abstract][Full Text] [Related]
11. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma.
Aarntzen EH; Bol K; Schreibelt G; Jacobs JF; Lesterhuis WJ; Van Rossum MM; Adema GJ; Figdor CG; Punt CJ; De Vries IJ
Cancer Res; 2012 Dec; 72(23):6102-10. PubMed ID: 23010076
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
13. The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients.
Charles J; Chaperot L; Revol B; Baudin M; Mouret S; Hamon A; Leccia MT; Plumas J; Aspord C
Pigment Cell Melanoma Res; 2018 Jan; 31(1):82-94. PubMed ID: 28741900
[TBL] [Abstract][Full Text] [Related]
14. Ongoing adaptive immune responses in the microenvironment of melanoma metastases.
van Baren N; Coulie PG
Ann N Y Acad Sci; 2013 May; 1284():62-5. PubMed ID: 23651195
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
[TBL] [Abstract][Full Text] [Related]
16. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma.
Kiss J; Tímár J; Somlai B; Gilde K; Fejôs Z; Gaudi I; Ladányi A
Pathol Oncol Res; 2007; 13(1):21-31. PubMed ID: 17387385
[TBL] [Abstract][Full Text] [Related]
17. Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells.
Berger TG; Haendle I; Schrama D; Lüftl M; Bauer N; Pedersen LØ; Schuler-Thurner B; Hohenberger W; Straten Pt Pt; Schuler G; Becker JC
Int J Cancer; 2004 Aug; 111(2):229-37. PubMed ID: 15197776
[TBL] [Abstract][Full Text] [Related]
18. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.
Ladányi A; Somlai B; Gilde K; Fejös Z; Gaudi I; Tímár J
Clin Cancer Res; 2004 Jan; 10(2):521-30. PubMed ID: 14760073
[TBL] [Abstract][Full Text] [Related]
19. Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Front Immunol; 2018; 9():3101. PubMed ID: 30774636
[TBL] [Abstract][Full Text] [Related]
20. Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.
Hadler-Olsen E; Wirsing AM
Br J Cancer; 2019 Apr; 120(7):714-727. PubMed ID: 30808992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
